Kevin McKernan

But all the research labs that just want to take a tiny piece of the virus out and say, I want to study what this Omicron thing is doing in the laboratory, they've got to be very careful if they put that into a shuttle vector that can infect humans and E. coli. That can't get out. Because, yes, the Seattle paper showed it can travel to housemates of the people working in the lab.

But all the research labs that just want to take a tiny piece of the virus out and say, I want to study what this Omicron thing is doing in the laboratory, they've got to be very careful if they put that into a shuttle vector that can infect humans and E. coli. That can't get out. Because, yes, the Seattle paper showed it can travel to housemates of the people working in the lab.

But all the research labs that just want to take a tiny piece of the virus out and say, I want to study what this Omicron thing is doing in the laboratory, they've got to be very careful if they put that into a shuttle vector that can infect humans and E. coli. That can't get out. Because, yes, the Seattle paper showed it can travel to housemates of the people working in the lab.

So they have to make sure that when they do those studies that they have a kill switch in those plasmas to some extent that doesn't allow it to jump between different organisms. Like only put in a million, something that can replicate in a million cells or only a coli but not both. Or they've got to just track them a lot more carefully.

So they have to make sure that when they do those studies that they have a kill switch in those plasmas to some extent that doesn't allow it to jump between different organisms. Like only put in a million, something that can replicate in a million cells or only a coli but not both. Or they've got to just track them a lot more carefully.

So they have to make sure that when they do those studies that they have a kill switch in those plasmas to some extent that doesn't allow it to jump between different organisms. Like only put in a million, something that can replicate in a million cells or only a coli but not both. Or they've got to just track them a lot more carefully.

So, you know, if Rand Paul's listening or anyone who's working on sort of the biosafety now thing, they have to look into that Seattle paper and they have to take a look at the data that we found in this colon cancer thing to see, is it anywhere else? Like start now. Using PCR to screen tumor biopsies. These tumor biopsies, people throw them out after two years.

So, you know, if Rand Paul's listening or anyone who's working on sort of the biosafety now thing, they have to look into that Seattle paper and they have to take a look at the data that we found in this colon cancer thing to see, is it anywhere else? Like start now. Using PCR to screen tumor biopsies. These tumor biopsies, people throw them out after two years.

So, you know, if Rand Paul's listening or anyone who's working on sort of the biosafety now thing, they have to look into that Seattle paper and they have to take a look at the data that we found in this colon cancer thing to see, is it anywhere else? Like start now. Using PCR to screen tumor biopsies. These tumor biopsies, people throw them out after two years.

Unless they paraffin fix them, they can start longer. But most biopsies are gone in two years. That's crazy. So they've got to go and start looking to see, is this an N of 1? Or are there other turbo cancers out there that are spike positive and have plasmids in them that are transmissible?

Unless they paraffin fix them, they can start longer. But most biopsies are gone in two years. That's crazy. So they've got to go and start looking to see, is this an N of 1? Or are there other turbo cancers out there that are spike positive and have plasmids in them that are transmissible?

Unless they paraffin fix them, they can start longer. But most biopsies are gone in two years. That's crazy. So they've got to go and start looking to see, is this an N of 1? Or are there other turbo cancers out there that are spike positive and have plasmids in them that are transmissible?

Because if spike is, in fact, causing tumor cancers, they have a transmissible form of spike going through all the research laboratories right now.

Because if spike is, in fact, causing tumor cancers, they have a transmissible form of spike going through all the research laboratories right now.

Because if spike is, in fact, causing tumor cancers, they have a transmissible form of spike going through all the research laboratories right now.

Well, it would move. Whether it would manifest in cancer in every patient is something I can't predict. But they at least should be able to track it with PCR. You can go and track the, like, okay, is it leaking anywhere? Is it jumping from person to person? And are we finding it in more than just N of 1 biopsies here?

Well, it would move. Whether it would manifest in cancer in every patient is something I can't predict. But they at least should be able to track it with PCR. You can go and track the, like, okay, is it leaking anywhere? Is it jumping from person to person? And are we finding it in more than just N of 1 biopsies here?

Well, it would move. Whether it would manifest in cancer in every patient is something I can't predict. But they at least should be able to track it with PCR. You can go and track the, like, okay, is it leaking anywhere? Is it jumping from person to person? And are we finding it in more than just N of 1 biopsies here?

We found it in both biopsies, but it was the same person, two different time points. But actually, we had three time points. They all had it. But the sequencing was only done on the first and last biopsy. But we do have to see if there's a trend here. If they keep finding this plasmid in other biopsies from people with turbo cancer, okay, that starts to build a thesis here.

We found it in both biopsies, but it was the same person, two different time points. But actually, we had three time points. They all had it. But the sequencing was only done on the first and last biopsy. But we do have to see if there's a trend here. If they keep finding this plasmid in other biopsies from people with turbo cancer, okay, that starts to build a thesis here.